Attison Global, a visionary company at the forefront of transforming the healthcare landscape. Our unwavering commitment to innovation and collaboration drives our pursuit of excellence in the ever-evolving realm of healthcare.
Meet the dynamic duo behind Attison Global, a powerhouse team committed to driving innovation in healthcare. With their diverse backgrounds and complementary expertise, they are revolutionizing the industry by leveraging their unique skills and shared passion for transformative change.
COVID-19 remains a threat to the entire world. In an attempt to curb its spread and facilitate its treatment, the technological tool that is Artificial Intelligence (AI) is being researched as a potential alternative to conventional methods.
The novel SARS-CoV-2 infection has ripped through international health systems and protocols causing unprecedented mortality, morbidity and global trade deficits amounting to billions. Various monoclonal antibodies have been proposed for use in the treatment of COVID-19 infections
The Coronavirus disease 2019 (COVID-19) pandemic is caused by rapidly spreading pathogenic virus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that affects vast majority of population worldwide.
